Anavex Life Sciences (AVXL) News Today → Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad) Free AVXL Stock Alerts $4.44 -0.11 (-2.42%) (As of 02:18 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 20 at 6:42 AM | americanbankingnews.comAnavex Life Sciences Corp. (NASDAQ:AVXL) Director Steffen Thomas Buys 5,000 SharesMay 18 at 10:41 AM | insidertrades.comSteffen Thomas Acquires 5,000 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) StockMay 17 at 6:52 AM | marketbeat.comAnavex Life Sciences Corp. (NASDAQ:AVXL) Director Steffen Thomas Purchases 5,000 SharesAnavex Life Sciences Corp. (NASDAQ:AVXL - Get Free Report) Director Steffen Thomas purchased 5,000 shares of the business's stock in a transaction on Wednesday, May 15th. The stock was purchased at an average price of $4.52 per share, with a total value of $22,600.00. Following the purchase, the director now owns 5,000 shares of the company's stock, valued at $22,600. The purchase was disclosed in a legal filing with the SEC, which is available through this link.May 14, 2024 | globenewswire.comAnavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQMay 13, 2024 | prnewswire.comShareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreMay 12, 2024 | americanbankingnews.comHC Wainwright Reiterates "Buy" Rating for Anavex Life Sciences (NASDAQ:AVXL)May 10, 2024 | marketbeat.comAnavex Life Sciences (NASDAQ:AVXL) Releases Earnings Results, Hits EstimatesAnavex Life Sciences (NASDAQ:AVXL - Get Free Report) announced its quarterly earnings data on Thursday. The biotechnology company reported ($0.13) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.13). During the same period in the prior year, the firm posted ($0.17) EPS.May 10, 2024 | businesswire.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Anavex Life Sciences Corp. (AVXL)May 10, 2024 | finance.yahoo.comAnavex Life Sciences Corp. (NASDAQ:AVXL) Q2 2024 Earnings Call TranscriptMay 10, 2024 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Anavex Life Sciences (NASDAQ:AVXL)HC Wainwright reissued a "buy" rating and issued a $40.00 price objective on shares of Anavex Life Sciences in a research note on Friday.May 10, 2024 | prnewswire.comShareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreMay 9, 2024 | markets.businessinsider.comBuy Rating on Anavex Life Sciences Amid Promising Alzheimer’s Drug ProspectsMay 9, 2024 | markets.businessinsider.comAVXL Stock Earnings: Anavex Life Sciences Misses EPS for Q2 2024May 9, 2024 | uk.finance.yahoo.comAnavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business UpdateMay 9, 2024 | finanznachrichten.deAnavex Life Sciences Corp.: Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business UpdateMay 9, 2024 | globenewswire.comAnavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business UpdateMay 8, 2024 | prnewswire.comBERGER MONTAGUE PC ANNOUNCES THE FILING OF A CLASS ACTION COMPLAINT TO RECOVER LOSSES FOR INVESTORS WHO PURCHASED ANAVEX LIFE SCIENCES CORPORATION (NASDAQ: AVXL)May 8, 2024 | prnewswire.comLevi & Korsinsky Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - AVXLMay 7, 2024 | prnewswire.comSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the FirmMay 7, 2024 | prnewswire.comThe Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) ShareholdersMay 6, 2024 | prnewswire.comAVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud LawsuitMay 6, 2024 | prnewswire.comShareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreMay 5, 2024 | stockhouse.comIMMINENT AVXL DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit!May 5, 2024 | markets.businessinsider.comONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex Life SciencesMay 5, 2024 | markets.businessinsider.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex Life SciencesMay 3, 2024 | prnewswire.comSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AnavexMay 3, 2024 | prnewswire.comAnavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXLMay 2, 2024 | prnewswire.comAVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud LawsuitMay 2, 2024 | markets.businessinsider.comDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex Life SciencesMay 2, 2024 | globenewswire.comAnavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024May 1, 2024 | prnewswire.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Corporation Lawsuit - AVXLApril 29, 2024 | prnewswire.comAVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud LawsuitApril 28, 2024 | markets.businessinsider.comDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex Life SciencesApril 28, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Anavex Life Sciences Corp. - AVXLApril 26, 2024 | markets.businessinsider.comShareholders that lost money on Anavex Life Sciences Corporation (AVXL) should contact Levi & Korsinsky about pending Class Action - AVXLApril 26, 2024 | prnewswire.comMay 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXLApril 25, 2024 | prnewswire.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AnavexApril 23, 2024 | prnewswire.comSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the FirmApril 22, 2024 | prnewswire.comAVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud LawsuitApril 22, 2024 | prnewswire.comAnavex Life Sciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your Rights - AVXLApril 20, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Anavex Life Sciences Corp. - AVXLApril 19, 2024 | prnewswire.comContact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL)April 16, 2024 | morningstar.comAnavex Life Sciences CorpApril 16, 2024 | prnewswire.comThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXLApril 15, 2024 | prnewswire.comAVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud LawsuitApril 15, 2024 | marketbeat.comAnavex Life Sciences Corp. (NASDAQ:AVXL) Sees Large Growth in Short InterestAnavex Life Sciences Corp. (NASDAQ:AVXL - Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 22,120,000 shares, an increase of 10.6% from the March 15th total of 20,000,000 shares. Based on an average daily trading volume, of 1,280,000 shares, the days-to-cover ratio is presently 17.3 days.April 15, 2024 | prnewswire.comAnavex Life Sciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your Rights - AVXLApril 13, 2024 | prnewswire.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AnavexApril 12, 2024 | stockhouse.comSHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses to Contact the FirmApril 12, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Anavex Life Sciences Corp. - AVXL Get Anavex Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AVXL and its competitors with MarketBeat's FREE daily newsletter. Email Address Everybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. AVXL Media Mentions By Week AVXL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVXL News Sentiment▼0.290.42▲Average Medical News Sentiment AVXL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVXL Articles This Week▼53▲AVXL Articles Average Week Get Anavex Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AVXL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TRML News AURA News SLDB News TNYA News MGTX News CRBU News BDTX News REPL News CCCC News JSPR News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVXL) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldBiden Nomination CANCELED?The Freeport SocietyDoes this make you sick?Allegiance GoldDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anavex Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
